Which has the lower trailing P/E, SOLV or UTHR?

SOLV has the lower trailing P/E: SOLV trades at 10.94 and UTHR at 18.38. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, SOLV or UTHR?

Over the past five years, UTHR grew revenue faster — SOLV at a 2.72% CAGR versus UTHR at 14.68%.

Is SOLV or UTHR more profitable?

UTHR runs the higher net margin — SOLV at 17.26% versus UTHR at 41.56%.

Solventum Corporation (SOLV) vs United Therapeutics Corporation (UTHR)

A side-by-side comparison of Solventum Corporation and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.

SOLV

Solventum Corporation

$15.51B

$89.57HealthcareAt close: Aug 21, 2026, 4:00 PM ET

UTHR

United Therapeutics Corporation

$21.78B

$513.12HealthcareAt close: Aug 21, 2026, 4:00 PM ET

Total return — SOLV vs UTHR

growth of $100 · dividends reinvested · last 2y

SOLV +12.0% (+5.8%/yr)UTHR +116.6% (+47.2%/yr)UTHR compounded faster over this window

SOLV UTHR

SOLV vs UTHR: by the numbers

•UTHR is the larger company ($21.78B vs $15.51B market cap).
•SOLV trades at the lower trailing earnings multiple (10.94 vs 18.38 P/E), one valuation lens rather than an overall verdict.
•UTHR converts more revenue to profit (41.56% vs 17.26% net margin).
•UTHR grew revenue faster over the past five years (14.68% vs 2.72% CAGR).

Metrics side by side

Valuation

Metric	SOLV	UTHR
P/E ratio	10.94	18.38
Forward P/E	12.51	19.63
P/S ratio	1.88	7.45
P/B ratio	3.25	3.67
EV / EBITDA	7.20	14.51
FCF yield	N/A	4.65%

Profitability

Metric	SOLV	UTHR
Gross margin	54.69%	86.14%
Operating margin	24.99%	44.49%
Net margin	17.26%	41.56%
ROE	29.88%	20.48%
ROIC	15.85%	17.69%

Growth (annualized)

Metric	SOLV	UTHR
Revenue CAGR (5Y)	2.72%	14.68%
EPS CAGR (5Y)	6.26%	20.93%
FCF CAGR (5Y)	N/A	14.31%
Total return CAGR (5Y)	N/A	20.22%

Frequently asked

Which has the lower trailing P/E, SOLV or UTHR?: SOLV has the lower trailing P/E: SOLV trades at 10.94 and UTHR at 18.38. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, SOLV or UTHR?: Over the past five years, UTHR grew revenue faster — SOLV at a 2.72% CAGR versus UTHR at 14.68%.
Is SOLV or UTHR more profitable?: UTHR runs the higher net margin — SOLV at 17.26% versus UTHR at 41.56%.

Go deeper

Full SOLV analysis Full UTHR analysis Interactive comparison tool

Dig into the metrics

Solventum P/E ratio United Therapeutics P/E ratio Solventum ROE United Therapeutics ROE Solventum operating margin United Therapeutics operating margin Solventum revenue growth United Therapeutics revenue growth Solventum free cash flow United Therapeutics free cash flow

Solventum & United Therapeutics appear in these rankings

Highest ROE Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.